59 results on '"Sahin, Deniz"'
Search Results
2. Taxonomy of Interventions to Reduce Acute Care Transfers From Long-term Care Homes: A Systematic Scoping Review
Catalog
Books, media, physical & digital resources
3. Front-line emergency department nurses’ and physicians’ assessments of processes of elder-friendly care for quality improvement
4. End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA
5. Effects of leptin, ghrelin and neuropeptide y on spike-wave discharge activity and certain biochemical parameters in WAG/Rij rats with genetic absence epilepsy
6. Impact of bone marrow biopsy on response assessment in immunochemotherapy-treated lymphoma patients in GALLIUM and GOYA
7. The Turkish experience with therapeutic plasma exchange: A national survey
8. Antagonism of adenosinergic system decrease SWD occurrence via an increment in thalamic NFkB and IL-6 in absence epilepsy
9. Enhancement of docosahexaenoic acid (DHA) and beta-carotene production in Schizochytrium sp. using symbiotic relationship with Rhodotorula glutinis
10. Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial
11. How Older Adults Experience an Emergency Department Visit: Development and Validation of Measures
12. Peripheral blood stem cell collection for allogeneic hematopoietic stem cell transplantation: Practical implications after 200 consequent transplants
13. Factors affecting nursing staff use of a communication tool to reduce potentially preventable acute care transfers in long-term care
14. Comparison of echocardiographic findings in patients with nonfunctioning adrenal incidentalomas
15. Changes in electroencephalographic characteristics and blood-brain barrier permeability in WAG/Rij rats with cortical dysplasia
16. The effect of leptin, ghrelin, and neuropeptide-Y on serum Tnf-Α, Il-1β, Il-6, Fgf-2, galanin levels and oxidative stress in an experimental generalized convulsive seizure model
17. The utility of thromboelastometry in prophylactic platelet transfusion for hematological malignancies
18. The effect of a selective neuronal nitric oxide synthase inhibitor 3-bromo 7-nitroindazole on spatial learning and memory in rats
19. Preconcentration of Cd(II) and Cu(II) ions by coprecipitation without any carrier element in some food and water samples
20. Total-and lipid-associated sialic acid in serum and thrombocytes in patients with chronic heart failure
21. Synthesis of some new 1,3,4-thiadiazol-2-ylmethyl-1,2,4-triazole derivatives and investigation of their antimicrobial activities
22. Analysis of spike-wave discharges in rats using discrete wavelet transform
23. Baseline SUVmax did not predict histological transformation in follicular lymphoma in the phase 3 GALLIUM study
24. Allogeneic Stem Cell Transplantation for Relapsed and/or Refractory Hodgkin Lymphoma: A Multicenter Real World Experience
25. Genetically engineered polypeptides for inorganics: A utility in biological materials science and engineering
26. Theophylline, a methylxanthine derivative, suppresses absence epileptic seizures in WAG/Rij rats
27. Recil 2017 Criteria Demonstrated Similar Prognostic Value and Detected a Comparable Treatment Difference between Obinutuzumab- and Rituximab-Chemotherapy Compared with Cheson 2007 and Lugano 2014 Criteria in Patients with Previously Untreated Advanced-Stage Follicular Lymphoma
28. Impact of an Established National Donor Registry on Transplant Outcome: Turkok Experience in Turkey
29. Allogeneic Hematopoietic Cell Transplantation (AHCT) in Post Infusion Cyclophosphamide (PIC) Era: The Switch from Anti-Thymocyte Globulin (ATG) to PIC for Graft Versus Host Disease (GVHD) Prophylaxis in AHCT from Alternative Donors
30. A Fully Automated Measurement of Total Metabolic Tumor Burden in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
31. Patient-Level Meta-Analysis of End-of-Therapy PET-CR as a Surrogate Endpoint for PFS and OS in Patients with Previously Untreated DLBCL: Implications for Clinical Trial Design
32. Final Analysis of GOYA: A Randomized, Open-Label, Phase III Study of Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
33. A Prognostic Model Integrating PET-Derived Quantitative Parameters and Image Texture Analyses Using Radiomics in a Large Prospective Phase III Trial, GOYA
34. Complete Response Status According to RECIL 2017 Criteria Shows High Concordance with Lugano 2014 Criteria and Is Highly Prognostic for Outcome in Previously Untreated Patients with CD20-Positive Diffuse Large B-Cell Lymphoma (DLBCL)
35. Haploidentical Versus Unrelated Donor Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia: Single Center Experience
36. Epigenetic Regulation of the ‘Peroxisome Proliferator Activating Receptor-Gamma’ Gene in Acute Myeloid Leukemia Patients
37. Baseline Suvmax Did Not Predict Histological Transformation from Follicular Lymphoma to Aggressive Lymphoma in the Phase III GALLIUM Study
38. Baseline PET-Derived Metabolic Tumor Volume Metrics Did Not Predict Outcomes in Follicular Lymphoma Patients Treated with First-Line Immunochemotherapy and Antibody Maintenance in the Phase III GALLIUM Study
39. Bone Marrow Biopsy Impacts Response Assessment in a Minority of Patients with Follicular Lymphoma and Diffuse Large B-Cell Lymphoma Treated with Immunochemotherapy: Results from the Randomized Phase III GALLIUM and GOYA Trials
40. Comparing Conditioning Regimens for Autologous Stem Cell Transplantation in Lymphoma Patients
41. 498 - Is There Any Room for Allogeneic Hematopoetic Stem Cell Transplantation in Relapse/Refractory Lymphoma: Single Center Experience
42. 424 - Should We Start Peripheral Blood Stem Cell Collection for Allogeneic Transplantation on the Fifth Day?
43. The Impact of Foundation of the National Turkish Donor Registry, Turkok on Donor Matching Kinetics
44. Tet1 promotes leukemic growth of AML1-ETO+ AML via 5-hydroxymethylcytosine marks and its oncogenic role and high expression can be antagonized using Olaparib, an inhibitor of its binding partner PARP1
45. 352 - Allogenenic Hematopoetic Cell Transplantation in AML at CR1: Related vs Unrelated vs Haploidentical Donors
46. The PARP Inhibitor Olaparib Antagonizes Leukemic Growth Induced By TET1 Overexpression in AML1-ETO Positive Acute Myeloid Leukemia
47. TET1 Promotes Leukemic Growth in T-ALL Via Maintenance of 5-Hydroxymethylation Marks and Can be Antagonized By the PARP Inhibitor Olaparib
48. PP-023 Relationship between Exercise Testing and Variations in Hematologic Parameters
49. OP-062 Aortic Elastic Properties Do Not Differ in Patients With Mitral Valve Prolapse
50. PP-097 Mild Hypereosinophilia During Warfarin Therapy: Report of Two Cases and a Short Review of the Literature
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.